Prostate-specific membrane antigen guided surgery.
Read time: 1 mins
Published:15th Nov 2019
Source: Journal of Nuclear Medicine
Availability: Pay for access, or by subscription
Ref.:J Nucl Med. 2019. pii: jnumed.119.232330.
Since its introduction in the diagnostic pathway of prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand positron-emission tomography (PET) has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making although its impact on patient outcomes still needs to be defined. One relatively new application, enabled through chemical and engineering efforts, is PSMA guided surgery. In this review, the potential of PSMA guided surgery is highlighted and its implications on lymph node dissection in primary and recurrent prostate cancer are discussed.